Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)
China · Delayed Price · Currency is CNY 77.87
+12.98 (20.00%)
At close: Jul 10, 2026
SHA:688710 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.83 | -30.52 | 147.78 | 194.45 | 135.41 | 94.69 |
Depreciation & Amortization | 86.23 | 86.23 | 79.5 | 74.16 | 69.75 | 49.57 |
Other Amortization | 9.78 | 9.78 | 6.63 | 6.79 | 6.46 | 6.12 |
Loss (Gain) From Sale of Assets | -21.2 | -21.2 | 0 | 0 | -0.21 | - |
Asset Writedown & Restructuring Costs | 3.77 | 3.77 | - | - | 22.55 | 7.2 |
Provision & Write-off of Bad Debts | 4.43 | 4.43 | 4.33 | 1.47 | 3.34 | 2.96 |
Other Operating Activities | 229.66 | 88.22 | 40.71 | 27.5 | 13.42 | 10.99 |
Change in Accounts Receivable | -104.52 | -104.52 | 23.44 | -49.24 | -61.37 | -51.82 |
Change in Inventory | -157.54 | -157.54 | 138.59 | -49.35 | -112.78 | -190.18 |
Change in Accounts Payable | 221.8 | 221.8 | -549.22 | -48.56 | 195.91 | 203.77 |
Change in Other Net Operating Assets | 8.29 | 8.29 | 16.38 | 16.4 | 23.64 | 15.74 |
Operating Cash Flow | 249.5 | 101.37 | -96.6 | 168.19 | 278.66 | 143.53 |
Operating Cash Flow Growth | - | - | - | -39.64% | 94.15% | 99.22% |
Capital Expenditures | -160.99 | -133.94 | -287.55 | -234.04 | -145.99 | -99.2 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.5 | - |
Other Investing Activities | 0.04 | 11.84 | -63.66 | -16.14 | 5.93 | - |
Investing Cash Flow | -160.95 | -122.1 | -351.21 | -250.18 | -139.55 | -99.2 |
Long-Term Debt Issued | - | - | 0.5 | 8 | - | - |
Short-Term Debt Repaid | - | - | - | - | -39 | - |
Long-Term Debt Repaid | - | -24.64 | -31.18 | -22.46 | - | - |
Total Debt Repaid | -24.64 | -24.64 | -31.18 | -22.46 | -39 | - |
Net Debt Issued (Repaid) | -24.64 | -24.64 | -30.68 | -14.46 | -39 | - |
Issuance of Common Stock | - | - | 627.74 | - | 570 | 370.59 |
Common Dividends Paid | -45.11 | -45.12 | -0.23 | -0.02 | -32.27 | -12.15 |
Other Financing Activities | 8.33 | 7.6 | - | - | -21.93 | 37.37 |
Financing Cash Flow | -61.42 | -62.16 | 596.83 | -14.47 | 476.8 | 395.81 |
Foreign Exchange Rate Adjustments | -0.74 | -0.47 | 0.02 | - | - | - |
Net Cash Flow | 26.38 | -83.36 | 149.04 | -96.46 | 615.91 | 440.13 |
Free Cash Flow | 88.5 | -32.57 | -384.15 | -65.85 | 132.67 | 44.33 |
Free Cash Flow Growth | - | - | - | - | 199.32% | 8814.66% |
Free Cash Flow Margin | 10.90% | -4.01% | -33.65% | -6.34% | 15.37% | 7.62% |
Free Cash Flow Per Share | 0.64 | -0.23 | -3.27 | -0.62 | 1.37 | 0.60 |
Cash Income Tax Paid | 6.27 | 9.49 | 26.75 | 43.38 | -196,829 | 9.23 |
Levered Free Cash Flow | 99.41 | 4.67 | -384.97 | -134.49 | 45.4 | 23.64 |
Unlevered Free Cash Flow | 103.89 | 10.01 | -377.68 | -126.98 | 53.78 | 30.51 |
Change in Working Capital | -39.36 | -39.36 | -375.54 | -136.18 | 45.2 | -25.78 |